Trainer Mike Maker has been notified by the Horseracing Integrity and Welfare Unit that his trainee Intermittent Fast tested ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

Despite some concerns, the appointments committee of the cabinet has approved the proposal for re-employment of Rajeev Singh ...

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...

The smaller companies in the sector are operating on thin margins and the tariffs could add on to the pressure forcing them ...

Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...

The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting prices to make the medications more af ...

Novo Nordisk is cutting the cost of its blockbuster weight-loss drug Wegovy in half for U.S. patients paying cash through its ...